Projects per year
Nonsteroidal anti-inflammatory drugs (NSAIDs) cause bronchospasm in susceptible patients with asthma, often termed aspirin-exacerbated respiratory disease (AERD), with the risk being greatest after acute exposure. Selective NSAIDs that preferentially inhibit COX-2 might be safer.
|Number of pages||16|
|Journal||Journal of Allergy and Clinical Immunology|
|Early online date||31 Dec 2013|
|Publication status||Published - Jul 2014|
- aspirin-exacerbated respiratory disease
- aspirin-induced asthma
- aspirin-sensitive asthma
- nonsteriodal anti-inflammatory agents
- COX-2 inhibitors
- Systematic review
FingerprintDive into the research topics of 'Safety risks for patients with aspirin-exacerbated respiratory disease after acute exposure to selective nonsteroidal anti-inflammatory drugs and COX-2 inhibitors: meta-analysis of controlled clinical trials'. Together they form a unique fingerprint.
- 1 Finished
A Multilevel Analysis of the Impact of Changes in Antimicrobial Prescribing on Antibiotic Resistance (Scottish Clinical Academic Training Fellowship)
Davey, P., Guthrie, B., Hernandez Santiago, V. & Marwick, C.
1/04/13 → 31/10/17
- Molecular and Clinical Medicine - Clinical Professor (Teaching and Research) of Allergy and Respiratory Medicine
- Population Health and Genomics - Wellcome Trust Clinical Research Fellow